Company intelligence / Profile preview

Sogeval

Ownership: Private
Employees: ~290
Development stage: Other

Overview

Sogeval is a French pharmaceutical company specializing in the development, manufacture, and marketing of veterinary medicines and animal health products. Founded in 1986 and headquartered in Laval, France, the company focuses on therapeutic areas such as dermatology, cardiology, and antibiotic therapy for companion animals and livestock. Sogeval is particularly recognized for its innovative delivery systems and leading brands like Douxo and Clavaseptin. In 2013, the company was acquired by Ceva Santé Animale, significantly expanding Ceva's portfolio in the companion animal sector. Today, Sogeval operates as a key subsidiary within the Ceva group, continuing to provide specialized veterinary solutions globally.

Therapeutic areas: NephrologyCardiovascularNeurologyDermatologyInfectious Diseases
Modalities: Small moleculeTopical formulationProtein
Industry: Veterinary

Beyond the preview

Go deeper on Sogeval.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sogeval.